Benchmark’s new sea lice treatment OK'd by Norwegian Medicines Agency

Ectosan Vet will be the first sea lice veterinary medicinal treatment to be introduced to the Norwegian salmon market in over a decade.

The granting of the marketing authorization is a major milestone and step forward for Benchmark.
The granting of the marketing authorization is a major milestone and step forward for Benchmark.Foto: Skjalg Bøhmer Vold
Published 5 July 2021, 03:43Updated 5 July 2021, 03:43
BenchmarksealiceNorwayEuropean CommissionSea lice